SHP465
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for SHP465, covering 2017-03-20 to 2020-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) [Phase 3]